Leadership
People behind Aquabiliti
Aquabiliti is led by a team of accomplished executives and operations professionals.
Aquabiliti is driven by the visionary leadership of the founding members of Advanced Scientific, Inc. (ASI), a team that fostered the exponential growth of ASI over three decades, establishing it as a global leader in advanced Single-Use Systems (SUS) for the healthcare and life sciences sectors. Leveraging extensive expertise in SUS, medical device manufacturing, and Water for Injection (WFI) generation, the Aquabiliti team has significantly enhanced our capabilities in engineering, packaging, and the development of cutting-edge single-use systems for WFI production.
Carl Martin
Chief Executive Officer
Prior to joining Aquabiliti in 2022, Mr. Martin was the CEO of Advanced Scientifics from 1990 to 2015. Under Mr. Martin’s leadership, Advanced Scientifics became a global leader in the design and manufacture of Single Use Systems for the Pharmaceutical and Biotechnology industries.
Mr. Martin’s expertise lies in his in-depth knowledge of plastics and machine engineering. Mr. Martin was instrumental in developing films for Advanced Scientifics’ Single Use Systems that withstood the critical testing criteria of the Pharmaceutical and Biotechnology industries. He directed the engineering development and building of Advanced Scientifics’ machine automation. In addition, Mr. Martin was at the forefront of developing new products and processes that led to many patents underwritten by Advanced Scientifics.
In February 2015, Mr. Carl Martin (CEO) and Mr. Smeltz orchestrated the sale of Advanced Scientifics to Thermo Fisher Scientifics at 27 times EBITDA. At the time of the sale, Advanced Scientifics had manufacturing locations in Millersburg, PA and Matamoros, MX and had sales offices in Europe, South America, and Asia. Both of Advanced Scientifics’ manufacturing facilities utilized Class 10,000 Clean Rooms for their manufacturing activities and both facilities were registered with the FDA and were ISO 13485:2003 certified.
Advanced Scientifics was pursued for acquisition by the likes of GE Healthcare, PALL Biopharmaceuticals, Merck Millipore, and many more large corporations. Thermo Fisher Scientifics, an $18 Billion international conglomerate, was the successful bidder.
Kent Smeltz
President
Mr. Smeltz earned Bachelor’s Degrees in Biology and Accounting and holds an MBA. As an undergraduate, Mr. Smeltz was recognized as the Senior Scholar Athlete of the Year and was a finalist for the Senior of the Year Award.
Before joining Aquabiliti in 2022, Mr. Smeltz held several accounting positions with Shell Oil and was a Senior Financial Accountant at TRW during the early 1990s. In 1994 Mr. Smeltz was hired as the Controller of Advanced Scientifics – a start-up Biological based entity. Mr. Smeltz was named President of Advanced Scientifics in 1997 and successfully introduced the firm’s fully integrated manufacturing software system and led the implementation of the firm’s FDA and ISO 13485:2003 certifications. Under Mr. Smeltz’s direction, Advanced Scientifics became a global leader in the design and manufacture of Single Use Systems for the Pharmaceutical and Biotechnology industries, with $95M in sales and over 420 employees.
In February 2015, Mr. Smeltz and Mr. Carl Martin (CEO) orchestrated the sale of Advanced Scientifics to Thermo Fisher Scientifics at 27 times EBITDA. At the time of the sale, Advanced Scientifics had manufacturing locations in Millersburg, PA and Matamoros, MX and had sales offices in Europe, South America, and Asia. Both of Advanced Scientifics’ manufacturing facilities utilized Class 10,000 Clean Rooms for their manufacturing activities and both facilities were registered with the FDA and were ISO 13485:2003 certified.
Advanced Scientifics was pursued for acquisition by the likes of GE Healthcare, PALL Biopharmaceuticals, Merck Millipore and many more large corporations. Thermo Fisher Scientifics, an $18 Billion international conglomerate, was the successful bidder.
Timir Patel, RPh
Managing Director and Chairman of the Board
Timir is a graduate of the University of Maryland School of Pharmacy and is a founding member of Aquabiliti since 2005, serving in various positions including as CEO from 2010-2022.
Timir began his healthcare career as a clinical pharmacist at Johns Hopkins Hospital in Baltimore. In 1992, he founded HCR of America, providing medical staffing services to a wide breadth of healthcare service providers. In 1996, he founded Millenia HealthCare, providing advanced and specialty infusion services to patients in ambulatory centers and their homes. Timir has also filed and been granted patents for medical device products.
Timir is committed to leveraging his varied background to innovate creative processes and products to enhance the Aquabiliti platform to bring to the life sciences, CGT, biotechnology, pharmaceutical and medical device sectors.